Hematology and Oncology
Parent: Medical Student Research Forum Posters
eScholarship stats: Breakdown by Item for April through July, 2026
| Item | Title | Total requests | Download | View-only | %Dnld |
|---|---|---|---|---|---|
| 0fr155c7 | MEK Inhibitor-Based Combination Strategies in Selected Molecular Subsets of Non-Small Cell Lung Cancer (NSCLC): rationale for the Design of Phase I Clinical Trials | 182 | 77 | 105 | 42.3% |
| 52n3v75r | Feasibility of a Symptomatic Screening Program for Early Detection of Gastric Cancer in Roatan, Honduras: Preliminary Results | 157 | 57 | 100 | 36.3% |
| 0009k5hn | Developing PRISM-Spanish: A psychosocial skills-based intervention for Spanish-speaking adolescents and young adults with cancer | 142 | 58 | 84 | 40.8% |
| 83v9859d | Pathogenesis of Endometriosis in Non-Human Primates: A Critical Literature Review | 137 | 53 | 84 | 38.7% |
| 2w0363m2 | Views of Non-Physician Stakeholders on Barriers & Facilitators to AYA Cancer Care in Latin America | 135 | 53 | 82 | 39.3% |
| 3990f2bj | Which non-phamacologic interventions are most effective at addressing chemotherapy related cognitive impairment (CRCI) in adolescent and young adult cancer survivors? | 131 | 52 | 79 | 39.7% |
| 0mp2m47j | High-plex spatial RNA profiling reveals cell type-specific biomarker expression in early-stage melanoma | 129 | 50 | 79 | 38.8% |
| 1kh858pm | Fragmentation of Care for Young Adults with Sickle Cell Disease in California | 124 | 54 | 70 | 43.5% |
| 65p3521q | Sarcopenia and Frailty as Predictors of Surgical Morbidity and Oncologic Outcomes in Retroperitoneal Sarcoma | 118 | 49 | 69 | 41.5% |
| 6kw1t6b1 | An Integrated Multidisciplinary Evaulation Platform and Early Experience for Precision Therapy in Resectable NSCLC | 118 | 50 | 68 | 42.4% |
| 07k290bw | Analyzing gene expression in androgen resistant prostate cancer | 116 | 52 | 64 | 44.8% |
| 54q9h3d9 | Low Income Areas Predict T Stage in Patients with Head and Neck Cancer | 108 | 36 | 72 | 33.3% |
| 3fj8d062 | Investigating the role of saposin B in HMA-mediated toxicity toward breast cancer cells | 97 | 38 | 59 | 39.2% |
| 2vc3315r | Amiloride Derivative Compound 10357 in the Treatment of B-Cell Acute Lymphoblastic Leukemia | 80 | 32 | 48 | 40.0% |
Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.